Serotonergic psychedelic: Difference between revisions

Line 203:

* {{cite journal|last1=Winter|first1=J.C|last2=Fiorella|first2=D.J|last3=Timineri|first3=D.M|last4=Filipink|first4=R.A|last5=Helsley|first5=S.E|last6=Rabin|first6=R.A|title=Serotonergic Receptor Subtypes and Hallucinogen-Induced Stimulus Control|journal=Pharmacology Biochemistry and Behavior|volume=64|issue=2|year=1999|pages=283–293|issn=00913057|doi=10.1016/S0091-3057(99)00063-5}}

* {{cite journal|last1=Nichols|first1=David E.|last2=Nichols|first2=Charles D.|title=Serotonin Receptors|journal=Chemical Reviews|volume=108|issue=5|year=2008|pages=1614–1641|issn=0009-2665|doi=10.1021/cr078224o}}

* {{cite journal|last1=Nichols|first1=David E|title=Hallucinogens|journal=Pharmacology & Therapeutics|volume=101|issue=2|year=2004|pages=131–181|issn=01637258|doi=10.1016/j.pharmthera.2003.11.002}}

* {{cite journal|last1=Vollenweider|first1=Franz X.|last2=Kometer|first2=Michael|title=The neurobiology of psychedelic drugs: implications for the treatment of mood disorders|journal=Nature Reviews Neuroscience|volume=11|issue=9|year=2010|pages=642–651|issn=1471-003X|doi=10.1038/nrn2884}}

* {{cite journal|last1=Johansen|first1=Pål-Ørjan|last2=Krebs|first2=Teri Suzanne|title=Psychedelics not linked to mental health problems or suicidal behavior: A population study|journal=Journal of Psychopharmacology|volume=29|issue=3|year=2015|pages=270–279|issn=0269-8811|doi=10.1177/0269881114568039}}

~~===Specific Examples===~~

* Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The Pharmacology of Lysergic Acid Diethylamide: A Review, 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x

* Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113

* Tylš, F., Páleníček, T., & Horáček, J. (2014). Psilocybin–summary of knowledge and new perspectives. European Neuropsychopharmacology, 24(3), 342-356. http://doi.org/10.1016/j.euroneuro.2013.12.006.

==References==

[[Category:Psychedelic]][[Category:Psychoactive substance]]

@@ Line 203: / Line 203: @@
 * {{cite journal|last1=Winter|first1=J.C|last2=Fiorella|first2=D.J|last3=Timineri|first3=D.M|last4=Filipink|first4=R.A|last5=Helsley|first5=S.E|last6=Rabin|first6=R.A|title=Serotonergic Receptor Subtypes and Hallucinogen-Induced Stimulus Control|journal=Pharmacology Biochemistry and Behavior|volume=64|issue=2|year=1999|pages=283–293|issn=00913057|doi=10.1016/S0091-3057(99)00063-5}}
 * {{cite journal|last1=Nichols|first1=David E.|last2=Nichols|first2=Charles D.|title=Serotonin Receptors|journal=Chemical Reviews|volume=108|issue=5|year=2008|pages=1614–1641|issn=0009-2665|doi=10.1021/cr078224o}}
-* {{cite journal|last1=Nichols|first1=David E|title=Hallucinogens|journal=Pharmacology & Therapeutics|volume=101|issue=2|year=2004|pages=131–181|issn=01637258|doi=10.1016/j.pharmthera.2003.11.002}}
-* {{cite journal|last1=Vollenweider|first1=Franz X.|last2=Kometer|first2=Michael|title=The neurobiology of psychedelic drugs: implications for the treatment of mood disorders|journal=Nature Reviews Neuroscience|volume=11|issue=9|year=2010|pages=642–651|issn=1471-003X|doi=10.1038/nrn2884}}
-* {{cite journal|last1=Johansen|first1=Pål-Ørjan|last2=Krebs|first2=Teri Suzanne|title=Psychedelics not linked to mental health problems or suicidal behavior: A population study|journal=Journal of Psychopharmacology|volume=29|issue=3|year=2015|pages=270–279|issn=0269-8811|doi=10.1177/0269881114568039}}
-===Specific Examples===
-* Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The Pharmacology of Lysergic Acid Diethylamide: A Review, 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x
-* Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113
-* Tylš, F., Páleníček, T., & Horáček, J. (2014). Psilocybin–summary of knowledge and new perspectives. European Neuropsychopharmacology, 24(3), 342-356. http://doi.org/10.1016/j.euroneuro.2013.12.006.
 ==References==
 <references/>
 [[Category:Psychedelic]][[Category:Psychoactive substance]]